Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Heart and Circulatory Physiology|December 6, 2005
Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytesShivani Mittra, Jean-Pierre Bourreau
Drug Discovery Today|March 18, 2008
From a glucocentric to a lipocentric approach towards metabolic syndromeShivani Mittra, Vinay S Bansal, Pradip K Bhatnagar
Atherosclerosis|January 3, 2006
Intermittent claudication: an overviewAshwinkumar V Meru, Shivani Mittra, Baskaran Thyagarajan, et al.
European Journal of Pharmacology|February 27, 2007
Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female ratsShivani Mittra, Shivani Malhotra, Krishna S Naruganahalli, et al.
Expert Opinion on Therapeutic Targets|December 14, 2007
Topiramate and type 2 diabetes: an old wine in a new bottleVivek Khanna, Surendar Arumugam, Subhasis Roy, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 10, 2004
Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis?Shivani Mittra, Jean-Marc Hyvelin, Qixian Shan, et al.
Expert Opinion on Biological Therapy|August 22, 2022
Biosimilars and interchangeable biosimilars: facts every prescriber, payor, and patient should know. Insulins perspectiveShashank R Joshi, Shivani Mittra, Praveen Raj, et al.
Diabetes, Obesity & Metabolism|February 7, 2023
Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysisShashank R Joshi, Gursharan Singh, Ashwani Marwah, et al.
Expert Opinion on Biological Therapy|June 27, 2024
Comparison of the efficacy and safety of rapid-acting insulin analogs, lispro versus aspart, in the treatment of diabetes: a systematic review of randomized controlled trialsRahul Kapur, Shivani Mittra, Geetanjali Tonpe, et al.
Indian Journal of Pharmacology|October 8, 2010
Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animalsJoseph A Davis, Shuchita Singh, Sachin Sethi, et al.
Pageof 2